ArticleVaccines2021

Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6.

Vedin Barve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.